About 2 900 reports

  • RISING INCIDENCE OF LUNG CANCER
  • LUNG CANCER LIQUID BIOPSY MARKET IN APAC

About Lung Cancer Liquid Biopsy A liquid biopsy helps to identify free-floating tumor DNA (also known as circulating DNA) within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. It...

  • Cancer
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Bladder cancer
  • Economic burden of bladder cancer

About Bladder Cancer Therapeutics The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the...

  • Cancer
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 6.2.2 Breast Cancer Liquid Biopsy Market & Forecast
  • 6.2.1 Lung Cancer Liquid Biopsy Market & Forecast

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Cancer
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • 1.1 BREAST CANCER
  • BREAST CANCER BY TYPES

‘Breast cancer’ defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also...

  • Cancer
  • World
  • Market Size
  • AbbVie Inc.
  • AstraZeneca PLC
  • Increasing incidence of prostate cancer
  • PROSTATE CANCER TESTING MARKET IN APAC

About Prostate Cancer Testing Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal...

  • Cancer
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MDxHealth SA
  • OPKO Health, Inc.
  • TREATMENT GUIDELINES FOR PROSTATE CANCER
  • AJCC STAGING OF PROSTATE CANCER

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026 Summary Prostate cancer (PCa) is the second most common cancer in men worldwide, after skin cancer. It accounts for 12% of all the cancers diagnosed in men, and thus represents a huge burden on healthcare systems. While...

  • Cancer
  • Hormone
  • Prostate Cancer
  • Therapy
  • PROVENGE group
  • BREAST CANCER: OVERVIEW
  • TREATMENT REGIMEN FOR BREAST CANCER

About Breast Cancer mAbs Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates...

  • Cancer
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • Cancer involving bone marrow
  • Effect of high cost of cancer drugs on cancer supportive care market

About Cancer Supportive Care Cancer supportive care drugs are used for the treatment of adverse effects caused due to the cancer treatment such as chemotherapy-induced anemia, CINV, bone metastasis, cancer pain, and others. Various class of drugs are used as cancer supportive care drugs. Some of the major drug class that involves...

  • Blood Disease
  • Cancer
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • CANCER GENE THERAPY MARKET IN APAC
  • Identifying factors impacting market growth

About Cancer Gene Therapy Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual’s body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy,...

  • Cancer
  • World
  • Forecast
  • Market Size
  • Celgene Corporation
  • Cancer statistics
  • Market segmentation by cancer type

About the Cancer Diagnostic Devices Market An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex...

  • Cancer
  • World
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Roche Group
  • Global Cervical Cancer Diagnostics
  • B: Cervical Cancer Flowchart

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies),...

  • Cancer
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • BREAST CANCER
  • BREAST CANCER

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. Today, HER2-positive breast cancer patients are living longer with their disease, thanks to established...

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Common Protein Cancer Biomarkers
  • 5.2 APPLICATIONS OF CANCER BIOMARKERS

Cancer Biomarkers Market The market for Global Cancer Biomarkers is highly dynamic. The Cancer Biomarkers market is expected to reach USD XXmillion by 2022 from USD XXmillion in 2016, at a CAGR of XX%. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers offers...

  • Cancer
  • North America
  • United States
  • World
  • Market Size
  • Cervical Cancer Key Statistics
  • 8.2 Canada Cervical Cancer Mortality

Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital Human Papilloma Virus (HPV) infection. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions is known to be highly effective...

  • Cancer
  • Cervical Cancer
  • Medical Device
  • Sexually Transmitted Disease
  • Forecast
  • Risk Factors for Pancreatic Cancer
  • 3.5.4 DIAGNOSED INCIDENT CASES OF PANCREATIC CANCER BY CANCER STAGES AT DIAGNOSIS

Pancreatic Cancer: Epidemiology Forecast to 2026 Summary Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found in developed countries (Michaud, 2004).Pancreatic cancer occurs when cells in the pancreas develop mutations in their...

  • Cancer
  • Japan
  • United States
  • World
  • Forecast
  • Blood Cancer
  • CANCER BY TYPES

Scope of the Report The report entitled “Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)”, provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the...

  • Cancer
  • Lung Cancer
  • World
  • Market Size
  • MetaStat, Inc.
  • PROGNOSIS FOR COLON AND RECTAL CANCER
  • STAGE DEFINITIONS FOR COLORECTAL CANCER

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased...

  • Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • TYPES OF LUNG CANCER
  • LUNG CANCER THERAPEUTICS MARKET IN EMEA

About Lung Cancer Therapeutics Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes...

  • Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Eli Lilly & Co.
  • Hoffmann-La Roche Inc.
  • Prostate cancer
  • TYPES OF PROSTATE CANCER

About Prostate Cancer Drugs Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology Care Foundation, globally, one in seven men will be diagnosed with the disease. About one in 35 men die due to prostate cancer. Growth in...

  • Cancer
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Sanofi S.A.
  • Cervical cancer: An overview
  • Global cervical cancer diagnostic testing market ($ billions)

About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages...

  • Cancer
  • Cervical Cancer
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.
  • MOLECULAR SUBTYPES OF BREAST CANCER
  • PROGNOSIS FOR BREAST CANCER

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. HER2-negative breast cancer...

  • Cancer
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • 2.2.1 Cancer Pain
  • Cancer Supportive Care Market, Global, Pipeline for Cancer Supportive Care

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets Summary Cancer is a disease characterized by abnormal cell growth and uncontrolled proliferation caused by a series of mutations that result in the...

  • Cancer
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Molecular Subtypes of Breast Cancer
  • Breast Cancer Therapeutics Market, Competitor Matrix for HER2-Positive Breast Cancer

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence Summary Breast cancer is a malignant neoplasm that begins in the breast tissue, which is made up of glands for milk production, called lobules, and the ducts...

  • Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group
  • Cervical Cancer Mortality Population
  • 7.1 Population - Cervical Cancer Test

Global Cervical Cancer Screening Market is projected to reach US$ 7 Billion by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human Papillomavirus (HPV) Virus. Cervical cancer is the fourth most common cancer...

  • Cancer
  • Southeast Asia
  • Western Europe
  • World
  • Forecast
  • TNM Classification of Nasopharyngeal Cancers, 2017
  • Stage Grouping for Nasopharyngeal Cancer, 2017

Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market Summary Head and neck squamous cell carcinoma is the sixth most common cancer, and its incidence is growing. The term head and neck cancer (HNC) refers...

  • Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • CANCER AUSTRALIA
  • BREAST CANCER NETWORK AUSTRALIA

Get 10% Free Customization in this Report Breast Cancer Screening Market is expected to be more than US$ 20 Billion by 2022. Breast cancer is the 2nd most common cancer among the women in the world. Number of breast cancer cases in less developed regions is higher than developed regions. Breast cancer mammography screening population...

  • Breast Cancer
  • Cancer
  • Southeast Asia
  • Western Europe
  • Forecast
  • Incidences of Cancer
  • Major Cancer Among Women

Executive Summary Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population,...

  • Cancer
  • Market Size
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company, Ltd

MARKET ##.

  • Cancer
  • Canada
  • Europe
  • United States
  • World
  • A) Cervical cancer
  • CANCER VACCINES MARKET, GLOBAL, SYMPTOMS OF KEY INDICATION CANCERS, 2016

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer is anticipated to become increasingly prevalent due to aging populations and rising levels of obesity in the developed world. Cancer vaccines...

  • Cancer
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • 9.1.3 INVESTIGATIONAL NEW DRUG/CLINICAL TRIAL AUTHORIZATION-FILED
  • CRC THERAPEUTICS MARKET, PROGNOSIS FOR CRC

Cancer Letters; ##(##): ##-## Globocan (2012).

  • Cancer
  • Therapy
  • World
  • Market Size
  • Merck & Co., Inc.